Cellular Integrin α5β1 and Exosomal ADAM17 Mediate the Binding and Uptake of Exosomes Produced by Colorectal Carcinoma Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Sep 2021
Historique:
received: 02 09 2021
accepted: 10 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 25 2 2023
Statut: epublish

Résumé

Approximately 25% of colorectal cancer (CRC) patients develop peritoneal metastasis, a condition associated with a bleak prognosis. The CRC peritoneal dissemination cascade involves the shedding of cancer cells from the primary tumor, their transport through the peritoneal cavity, their adhesion to the peritoneal mesothelial cells (PMCs) that line all peritoneal organs, and invasion of cancer cells through this mesothelial cell barrier and underlying stroma to establish new metastatic foci. Exosomes produced by cancer cells have been shown to influence many processes related to cancer progression and metastasis. In epithelial ovarian cancer these extracellular vesicles (EVs) have been shown to favor different steps of the peritoneal dissemination cascade by changing the functional phenotype of cancer cells and PMCs. Little is currently known, however, about the roles played by exosomes in the pathogenesis and peritoneal metastasis cascade of CRC and especially about the molecules that mediate their interaction and uptake by target PMCs and tumor cells. We isolated exosomes by size-exclusion chromatography from CRC cells and performed cell-adhesion assays to immobilized exosomes in the presence of blocking antibodies against surface proteins and measured the uptake of fluorescently-labelled exosomes. We report here that the interaction between integrin α5β1 on CRC cells (and PMCs) and its ligand ADAM17 on exosomes mediated the binding and uptake of CRC-derived exosomes. Furthermore, this process was negatively regulated by the expression of tetraspanin CD9 on exosomes.

Identifiants

pubmed: 34576100
pii: ijms22189938
doi: 10.3390/ijms22189938
pmc: PMC8471098
pii:
doi:

Substances chimiques

Fibronectins 0
Integrin alpha5beta1 0
Tetraspanin 29 0
ADAM17 Protein EC 3.4.24.86

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Economy, Industry and Competitiveness
ID : SAF2016-77096-R

Références

J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
PLoS One. 2012;7(3):e33350
pubmed: 22413019
Int J Cancer. 2007 Nov 15;121(10):2140-52
pubmed: 17582603
Cancers (Basel). 2019 Aug 10;11(8):
pubmed: 31405096
Am J Respir Cell Mol Biol. 2019 Mar;60(3):279-288
pubmed: 30321056
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Cell Adh Migr. 2017 Mar 4;11(2):187-195
pubmed: 28129015
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Mol Cancer Res. 2017 Jan;15(1):78-92
pubmed: 27758876
Sci Rep. 2019 Jul 19;9(1):10522
pubmed: 31324885
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Front Cell Dev Biol. 2021 Mar 18;9:640667
pubmed: 33816490
Int J Oncol. 2021 Jul;59(1):
pubmed: 34013358
Exp Biol Med (Maywood). 2021 May;246(9):1121-1138
pubmed: 33601913
Cell Mol Life Sci. 2011 Oct;68(19):3275-92
pubmed: 21365281
Molecules. 2021 Feb 10;26(4):
pubmed: 33579029
Exp Mol Med. 2014 Apr 04;46:e89
pubmed: 24699135
Front Immunol. 2018 Apr 30;9:863
pubmed: 29760699
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2088-2095
pubmed: 28571693
J Am Soc Nephrol. 2011 Sep;22(9):1682-95
pubmed: 21742730
J Cell Biol. 1989 Sep;109(3):1321-30
pubmed: 2527858
Int J Biol Sci. 2019 Jan 1;15(2):493-506
pubmed: 30745837
J Biol Chem. 2003 Jan 3;278(1):208-18
pubmed: 12411441
J Biol Chem. 2004 May 21;279(21):22377-86
pubmed: 14970227
World J Gastroenterol. 2015 Mar 21;21(11):3206-13
pubmed: 25805926
World J Surg Oncol. 2011 Apr 27;9:43
pubmed: 21521534
Can J Microbiol. 2008 Jan;54(1):37-47
pubmed: 18388970
Onco Targets Ther. 2020 Dec 31;13:13329-13344
pubmed: 33408483
Blood. 2005 Apr 1;105(7):2852-61
pubmed: 15591117
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Cell Commun Signal. 2021 Apr 23;19(1):47
pubmed: 33892745
Nanoscale. 2017 Sep 21;9(36):13693-13706
pubmed: 28880029
Trends Cancer. 2020 Mar;6(3):236-246
pubmed: 32101726
J Immunol Methods. 2011 Aug 31;371(1-2):91-6
pubmed: 21726562
Front Oncol. 2021 Mar 22;11:639159
pubmed: 33828985
Eur J Immunol. 1992 Dec;22(12):3111-9
pubmed: 1446704
Front Immunol. 2018 Nov 05;9:2474
pubmed: 30455686
J Biol Chem. 2016 Jan 22;291(4):1652-1663
pubmed: 26601950
J Oncol. 2019 Sep 19;2019:7407190
pubmed: 31641356
Cell Mol Life Sci. 2013 Feb;70(3):475-93
pubmed: 23052204
N Engl J Med. 2003 Jan 30;348(5):403-13
pubmed: 12556543
Front Immunol. 2014 Sep 16;5:442
pubmed: 25278937
J Cell Biol. 1992 May;117(3):659-70
pubmed: 1374069
Med Microbiol Immunol. 2020 Aug;209(4):461-471
pubmed: 32385608
Am Soc Clin Oncol Educ Book. 2015;:e208-11
pubmed: 25993175
Cancer Res. 1979 Dec;39(12):4914-24
pubmed: 498117
Int J Oncol. 2013 May;42(5):1793-800
pubmed: 23545805
Cancers (Basel). 2021 May 20;13(10):
pubmed: 34065529
Nat Commun. 2015 May 13;6:7164
pubmed: 25968605
Front Oncol. 2021 Jun 18;11:702510
pubmed: 34222025
Mol Cell Biol. 1990 Aug;10(8):4007-15
pubmed: 1695320

Auteurs

Beatriz Cardeñes (B)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.

Irene Clares (I)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.

Víctor Toribio (V)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Department of Molecular Biology, Faculty of Sciences, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Lucía Pascual (L)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.

Soraya López-Martín (S)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Department of Molecular Biology, Faculty of Sciences, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Alvaro Torres-Gomez (A)

Department of Immunology, Ophthalmology and Otorhinolaryngology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Ricardo Sainz de la Cuesta (R)

Department of Obstetrics and Gynecology, Hospital Universitario Quironsalud Madrid, 28223 Madrid, Spain.

Esther M Lafuente (EM)

Department of Immunology, Ophthalmology and Otorhinolaryngology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Manuel López-Cabrera (M)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.

María Yáñez-Mó (M)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Department of Molecular Biology, Faculty of Sciences, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Instituto de Investigación Sanitaria Hospital La Princesa, 28006 Madrid, Spain.

Carlos Cabañas (C)

Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Department of Immunology, Ophthalmology and Otorhinolaryngology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH